Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Premier Biomedical Inc (OTC: BIEI).

Full DD Report for BIEI

You must become a subscriber to view this report.


Recent News from (OTC: BIEI)

MoneyTV with Donald Baillargeon, 5/18
LOS ANGELES, CA / ACCESSWIRE / May 18, 2018 / Legal sports betting, pain relief, cryptocurrency, blockchain, CBD; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, ( http://www.moneytv.net ), f...
Source: ACCESSWIRE IA
Date: May, 18 2018 05:00
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire's "Stock Day" Podcast
PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTCBB:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to discuss recent company developments. Premier Biomedical consists of two groups: T...
Source: GlobeNewswire
Date: April, 26 2018 08:30
Premier Biomedical, Inc. CEO Letter - April 2018
JACKSON CENTER, PA / ACCESSWIRE / April 25, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI ); Greetings From The CEO And Staff At Premier Biomedical! It has been a very busy and eventful quarter for Premier Biomedical. Finance and Stock Performance Recent actions by FINRA whe...
Source: ACCESSWIRE
Date: April, 25 2018 08:00
MoneyTV with Donald Baillargeon, 4/13
LOS ANGELES, CA / ACCESSWIRE / April 13, 2018 / Pain relief, cancer treatment, blockchain and cryptocurrency, water cleanup, cannabis business, organic teas, US/China trade war; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all abo...
Source: ACCESSWIRE IA
Date: April, 13 2018 05:00
ICYMI - Premier Biomedical CEO Interviewed on MoneyTV
In Case You Missed It - Mr. Hartman Recaps the Company's History and Plans for the Future JACKSON CENTER, PA / ACCESSWIRE / March 29, 2018 / Premier Biomedical, Inc . (OTC PINK: BIEI ) President and CEO, William A. Hartman was interviewed again by host, Donald Baillargeon on MoneyT...
Source: ACCESSWIRE
Date: March, 29 2018 08:00
Premier Biomedical Inc., CEO William Hartman Visits Uptick Newswire's "Stock Day" with Everett Jolly
Phoenix, March 26, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical Inc., (OTC: BIEI) ("the Company"), today reviewed recent accomplishments in interview on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. Premier Biomedical consists of two divisions, one f...
Source: GlobeNewswire
Date: March, 26 2018 08:00
MoneyTV with Donald Baillargeon, 3/23
LOS ANGELES, CA / ACCESSWIRE / March 23, 2018 / Pain relief, medical imaging, water cleanup, cannabis business, solar and roofing, cloud, blockchain, Facebook; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what ...
Source: ACCESSWIRE IA
Date: March, 23 2018 05:00
MoneyTV with Donald Baillargeon, 3/9
LOS ANGELES, CA / ACCESSWIRE / March 9, 2018 / Blockchain, water cleanup, cannabis business, Chinese investors, cancer treatment, medical imaging; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happ...
Source: ACCESSWIRE IA
Date: March, 09 2018 05:00
MoneyTV with Donald Baillargeon, 3/2
LOS ANGELES, CA / ACCESSWIRE / March 2, 2018 / CBD oil, the blockchain, water cleanup, solar and roofing, cannabis business, Chinese investors, who want the POTUS job; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money a...
Source: ACCESSWIRE IA
Date: March, 02 2018 05:00
Premier Biomedical Inc. Searching For Development Partner To Advance Patent Pending Technology
Jackson Center, PA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC: " BIEI ") announced today they are actively searching for a partner to develop their patented extracorporeal treatment process in combination with their patent pending method for treating diseases thr...
Source: GlobeNewswire
Date: February, 28 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-06-270.500.500.500.407,277
2018-06-260.0020.0020.0020.00161,819,274
2018-06-250.0020.0020.00210.00185,087,010
2018-06-220.00180.0020.0020.0018672,800
2018-06-210.00220.0020.00220.0017987,535

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-06-261,306,2691,819,27471.8017Short
2018-06-252,944,5895,087,01057.8845Short
2018-06-22375,509672,80055.8129Short
2018-06-21368,200987,53537.2848Short
2018-06-201,267,4442,038,59462.1725Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BIEI.


About Premier Biomedical Inc (OTC: BIEI)

Logo for Premier Biomedical Inc (OTC: BIEI)

We are a research based company that intends to discover and develop medical treatments for humans. We have a three fold corporate focus: i develop and market pain management products, ii develop our proprietary Sequential Dialysis Technique to target cancer Alzheimer s disease, ALS, blood sepsis, leukemia and other life threatening cancers, and iii develop our proprietary drug candidate Feldetrex , a potential treatment for Multiple Sclerosis, Fibromyalgia, Neuropathic Pain and Traumatic Brain Injury. Our focus recently has been on our pain management products. We are engaged in several discussions to find a suitable partner to work with us on the anti cancer drug development.

 

 

 

Current Management

  • Mitchell S. Felder / CoFounder
  • William A. Hartman / President, CEO, CoFounder
  • Patricio F. Reyes / CTO
  • John Borza / Vice President
  • Heidi H. Carl / CFO, Corporate Secretary, Treasurer
  • Mitchell S. Felder / Chairman
  • John Borza /
  • Heidi H. Carl /
  • William A. Hartman /
  • John Pauly /
  • Patricio F. Reyes /
  • Jay Rosen /

Current Share Structure

  • Authorized: 1,000,000,000 - 02/16/2018
  • Issue and Outstanding: 0 - 02/16/2018
  • Float: 490,339,521 - 11/13/2017

 


Recent Filings from (OTC: BIEI)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 15 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: May, 04 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 03 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: April, 30 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: April, 26 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 12 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 28 2017

 

 


Daily Technical Chart for (OTC: BIEI)

Daily Technical Chart for (OTC: BIEI)


Stay tuned for daily updates and more on (OTC: BIEI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BIEI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIEI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BIEI and does not buy, sell, or trade any shares of BIEI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/